Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer

Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer Chantal Bernard-Marty, Fatima Cardoso, Martine J. Piccart Oncologist 2004; 9: 617-632 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the roles of hormonal treatment, chemotherapy, and biological agents in the therapy of metastatic breast cancer patients. Explain how to select the best available treatment for a metastatic breast cancer patient. Discuss the controversies and future developments of treatment modalities for metastatic breast cancer patients. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Nov. 23, 2004 Most Recent Review: Nov. 23, 2004* Most Recent Update: Nov. 23, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.